CIRCARE periodically sends out important updates on human subject research in the CIRCARE InfoMail. Our InfoMail contains news and information about human research protection, CIRCARE position statements, press releases, and policy documents.
Would you like to receive the CIRCARE Infomail? Follow this link to our InfoMail Subscription Form. We don't share the names and addresses of people who subscribe to the CIRCARE InfoMail for any reason.
2004-02-02 Testing Ecstasy on Subjects Diagnosed with PTSD and the Use of Internet Recruiting
Follow this link to find additional information on the MAPS ecstacy research.
2004-02-25 Relabeling ECT as a Low Risk Device Without Appropriate Research
Correction 2004-09-28: The CIRCARE InfoMail of 2004-02-25 reported inaccurate information. FDA had no plans to re-classify this device. Read FDA's letter in response to the citizen's petition (Docket No. 2003P-0555):
Kahan L. Letter to L. Andre re: Docket No. 2003P-0555. 2004-09-03. Available from http://www.fda.gov/ohrms/dockets/dailys/04/sep04/091504/03p-0555-let00002-vol2.pdf
2004-03-12 The Creation of a Database for Recording Adverse Events in Genetic Studies
2004-07-15 Neglect of Reporting Adverse Events
2004-08-09 An Ethical AIDS Study? The Use of Non-Standard Care
2004-10-16 Regarding the Failure of the Public Safety System For Drug Testing in the Case of Vioxx
Last Updated: 2006-04-25
If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page
All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education. Adobe® Reader :: ::
